Protagonist Therapeutics PTGX Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Protagonist Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's net margin?
- Protagonist Therapeutics (PTGX) reported net margin of -154.9% in Q1 2026.
- How has Protagonist Therapeutics's net margin changed year-over-year?
- Protagonist Therapeutics's net margin decreased by 672.8% year-over-year, from 27% to -154.9%.
- What is the long-term trend for Protagonist Therapeutics's net margin?
- Over 3 years (2021 to 2025), Protagonist Therapeutics's net margin has grown at a -14.9% compound annual growth rate (CAGR), from -458.9% to -282.8%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.